=Quest Diagnostics (DGX) reported earnings on reported earnings on Thur 21 Oct 21 (b/o)

 

Quest Diagnostics beats by $0.90, beats on revs; raises FY21 EPS above consensus, revs above consensus

• Reports Q3 (Sep) earnings of $3.96 per share, excluding non-recurring items, $0.90 better than the S&P Capital IQ Consensus of $3.06; revenues fell 0.6% year/year to $2.77 bln vs the $2.52 bln S&P Capital IQ Consensus.
• Co issues raised guidance for FY21, sees EPS of $13.50-13.90 from $11.65-12.35, excluding non-recurring items, vs. $12.34 S&P Capital IQ Consensus; sees FY21 revs of $10.45-10.65 bln from $9.84-10.09 bln vs. $10.13 bln S&P Capital IQ Consensus.